Exane Derivatives’s Freeport-McMoran FCX Stock Holding History

Exane Derivatives’s Portfolio FCX Stock Details FCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$97.6K	Sell	3,337 -38,521	-92%	-$1.54M	0.06%	266
2022 Q1	$2.08M	Sell	41,858 -38,726	-48%	-$1.72M	0.59%	31
2021 Q4	$3.36M	Buy	80,584 +19,152	+31%	+$728K	0.81%	16
2021 Q3	$2M	Buy	61,432 +17,693	+40%	+$623K	0.48%	38
2021 Q2	$1.56M	Sell	43,739 -50,041	-53%	-$1.95M	0.35%	59
2021 Q1	$3.09M	Buy	93,780 +48,229	+106%	+$1.56M	0.88%	25
2020 Q4	$1.19M	Buy	45,551 +37,795	+487%	+$786K	0.35%	61
2020 Q3	$121K	Hold	7,756	–	–	0.04%	276
2020 Q2	$89.7K	Sell	7,756 -8,081	-51%	-$74.1K	0.02%	311
2020 Q1	$107K	Sell	15,837 -538,589	-97%	-$5.64M	0.03%	275
2019 Q4	$7.19M	Buy	+554,426	New	+$6.09M	1.33%	14
2019 Q3	–	Sell	-777	Closed	-$9.02K	–	669
2019 Q2	$9.02K	Sell	777 -52,492	-99%	-$611K	﹤0.01%	460
2019 Q1	$686K	Buy	+53,269	New	+$644K	0.14%	137
2018 Q4	–	Sell	-5,448	Closed	-$76.1K	–	702
2018 Q3	$76.1K	Sell	5,448 -6,166	-53%	-$93.2K	0.01%	346
2018 Q2	$200K	Sell	11,614 -987,200	-99%	-$16.7M	0.03%	266
2018 Q1	$16.6M	Buy	998,814 +3,097	+0.3%	+$58.1K	3.31%	5
2017 Q4	$18.9M	Buy	995,717 +958,090	+2,546%	+$14.5M	3.26%	8
2017 Q3	$528K	Buy	+37,627	New	+$529K	0.1%	133
2017 Q2	–	Sell	-35,422	Closed	-$473K	–	650
2017 Q1	$473K	Buy	35,422 +22,251	+169%	+$320K	0.11%	137
2016 Q4	$174K	Sell	13,171 -36,311	-73%	-$465K	0.03%	208
2016 Q3	$537K	Sell	49,482 -5,579	-10%	-$64.2K	0.08%	149
2016 Q2	$613K	Sell	55,061 -6,755	-11%	-$74.8K	0.1%	117
2016 Q1	$639K	Sell	61,816 -14,622	-19%	-$103K	0.08%	118
2015 Q4	$517K	Buy	76,438 +4,824	+7%	+$46K	0.07%	113
2015 Q3	$694K	Buy	71,614 +1,094	+2%	+$13.1K	0.09%	105
2015 Q2	$1.31M	Buy	70,520 +4,930	+8%	+$102K	0.14%	78
2015 Q1	$1.24M	Buy	+65,590	New	+$1.3M	0.14%	86

Other funds holding FCX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's FCX Position: Q2 2022 in Review

Exane Derivatives reduced its Freeport-McMoran (FCX) stake by 92% in Q2 2022, selling an estimated $1.54M and leaving 3,337 shares worth $97.6K. The position accounts for 0.06% of the portfolio, ranked #266.

Exane Derivatives first reported a position in FCX in Q1 2015 and has held it in 27 quarters since. The position peaked at $18.9M in Q4 2017. 1,127 funds tracked by Wall St. Rank hold FCX as of Q2 2022.

Exane Derivatives held 3,337 shares of Freeport-McMoran worth $97.6K as of Q2 2022.
Exane Derivatives sold 38,521 Freeport-McMoran shares in Q2 2022, an estimated $1.54M.
Freeport-McMoran made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #266 holding.
Exane Derivatives first reported a position in Freeport-McMoran in Q1 2015 and has held it in 27 quarters since.
Exane Derivatives's Freeport-McMoran position peaked at $18.9M in Q4 2017.
1,127 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.